Loading…
This program is subject to change. Speakers are added as confirmations are received.
Please  note that preconference courses require separate registration.
Downloads:   Oral Abstracts   Poster Abstracts
Back To Schedule
Wednesday, July 11 • 12:30 - 12:42
Session 5 | Novel approaches to predict adverse fetal outcome: 5-4 ASPRE trial: incidence of preterm preeclampsia in patients fulfilling ACOG and NICE criteria according to risk by the FMF algorithm

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

ASPRE trial: incidence of preterm preeclampsia in patients fulfilling ACOG and NICE criteria according to risk by the FMF algorithm
Liona Poon
The Chinese University of Hong Kong, The Chinese University of Hong Kong, Shatin, Hong Kong SAR
Objectives
To report the incidence of preterm preeclampsia (PE) in women that fulfilled the screening criteria of the National Institute for Health and Clinical Excellence (NICE) and American Congress of Obstetricians and Gynecologists (ACOG) and compare the incidence in those that were screen positive and screen negative by the Fetal Medicine Foundation (FMF) algorithm.
Methods
This was a secondary analysis of data from the ASPRE study. The study population consisted of women with singleton pregnancies who had prospective screening for preterm-PE by means of the FMF algorithm that combines maternal factors and biomarkers at 11-13 weeks’ gestation. We estimated the incidence of preterm-PE in those fulfilling the NICE and ACOG criteria; in these patients we then calculated the incidence of preterm-PE in those that were screen negative relative to those that were screen positive by the FMF algorithm.
Results
34,573 women with singleton pregnancies were included. There were 239 (0.7%) cases of preterm-PE. At least one ACOG-criteria was fulfilled in 22,287 (64.5%) of pregnancies and the incidence of preterm-PE was 0.97%; in those that were FMF-screen-positive the incidence was 4.80%, in those that were screen-negative it was 0.25% and the relative incidence was 0.051.  In 1,392 (4.0%) pregnancies at least one NICE high-risk criteria was fulfilled and the incidence of preterm-PE was 5.17%; in the subgroups of screen-positive and screen-negative by the FMF algorithm the incidence of preterm-PE was 8.71% and 0.65%, respectively, and the relative incidence was 0.075.
Conclusions
In ACOG or NICE screen positive women that are screen negative by the FMF algorithm the risk of preterm-PE is reduced to within or below background levels. The results provide further evidence to support risk based screening using biomarkers. 

Moderators
avatar for Monique Haak

Monique Haak

Gynaecologist, Leiden University Medical Center (LUMC)
avatar for Sebastian Illanes

Sebastian Illanes

Feto Maternal Medicine, Universidad de los Andes

Speakers
avatar for Liona Poon

Liona Poon

Associate Professor, The Chinese University of Hong Kong, Department of Obstetrics and Gynaecology, Faculty of Medicine


Wednesday July 11, 2018 12:30 - 12:42 CEST
Okapi Room 2&3